Welcome to our dedicated page for B&G Foods news (Ticker: $BGS), a resource for investors and traders seeking the latest updates and insights on B&G Foods stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect B&G Foods's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of B&G Foods's position in the market.
B&G Foods, Inc. reported financial results for Q1 2024, impacted by the Green Giant U.S. shelf‑stable divestiture. Net sales decreased 7.1%, with adjusted diluted EPS down 33.3% and net loss of $40.2 million. The company revised full-year guidance: net sales $1.955B-$1.985B, adjusted EBITDA $300M-$320M, and adjusted diluted EPS $0.75-$0.95.